CME Group Inc. (NASDAQ:CME) Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC reduced its stake in shares of CME Group Inc. (NASDAQ:CME) by 27.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 618,589 shares of the financial services provider’s stock after selling 230,100 shares during the period. Renaissance Technologies LLC owned 0.17% of CME Group worth $121,615,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Aveo Capital Partners LLC purchased a new stake in shares of CME Group in the fourth quarter valued at $226,000. 9258 Wealth Management LLC grew its holdings in shares of CME Group by 3.7% during the fourth quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock worth $663,000 after buying an additional 113 shares in the last quarter. Gryphon Financial Partners LLC acquired a new position in shares of CME Group in the fourth quarter valued at approximately $547,000. Beacon Pointe Advisors LLC lifted its stake in shares of CME Group by 6.8% during the fourth quarter. Beacon Pointe Advisors LLC now owns 9,200 shares of the financial services provider’s stock valued at $1,938,000 after buying an additional 588 shares during the period. Finally, Meridian Wealth Management LLC boosted its position in CME Group by 8.0% during the fourth quarter. Meridian Wealth Management LLC now owns 2,204 shares of the financial services provider’s stock worth $464,000 after acquiring an additional 163 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Performance

Shares of CME stock opened at $216.99 on Monday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $78.13 billion, a PE ratio of 24.69, a P/E/G ratio of 8.85 and a beta of 0.55. The company’s fifty day simple moving average is $205.69 and its 200-day simple moving average is $207.50. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the previous year, the firm posted $2.30 earnings per share. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. As a group, equities research analysts anticipate that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.12%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Analysts Set New Price Targets

A number of research analysts have weighed in on CME shares. Piper Sandler reissued an “overweight” rating and set a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. JPMorgan Chase & Co. raised their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Barclays raised their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and an average target price of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.